Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nogol Rahbin"'
Autor:
Anna-Karin Siosteen, Lennart Blomqvist, Rolf Hultcrantz, Nogol Rahbin, Soo Aleman, Karin Hagen, A. Elvin
Publikováno v:
Acta Radiologica. 49:251-257
Background: Hepatitis C virus (HCV)-associated liver cirrhosis provides a major preneoplastic condition for hepatocellular carcinoma (HCC). Ultrasonography (US) is usually used for screening of HCC, but needs improvement. Purpose: To assess whether u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b308ce01a4643043fb69b01542b0abb1
https://doi.org/10.1080/02841850701813831
https://doi.org/10.1080/02841850701813831
Autor:
Soo Aleman, Loa Davidsdottir, Fredrik Granath, Nina Rose, Anders Ekbom, Hans Verbaan, Hans Norrgren, Magnus Hedenstierna, Per Stål, Ola Weiland, Rolf Hultcrantz, Nogol Rahbin, Tony Carlsson
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 57(2)
Background. The long-term effect of sustained virologic response (SVR) to antiviral therapy on the risk of developing hepatocellular carcinoma (HCC), liver complications, liver-related death, and overall death in hepatitis C virus (HCV)–infected pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11e7f8cb748b8775ca8a115685ea94b4
https://pubmed.ncbi.nlm.nih.gov/23616493
https://pubmed.ncbi.nlm.nih.gov/23616493
Autor:
Nogol Rahbin, Lars Frelin, Erwin Daniel Brenndörfer, Matti Sällberg, Rolf Hultcrantz, Soo Aleman
Publikováno v:
Biochemical and biophysical research communications. 433(1)
The hepatitis C virus (HCV) non-structural 3 (NS3) protein plays key roles in both the viral life cycle and in the modulation of intrahepatic signaling and immunity. We recently showed that NS3 cleaves the T cell protein tyrosine phosphatase (TCPTP).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46e4991cbd3f6287704eaa5e2ba4ca6
https://pubmed.ncbi.nlm.nih.gov/23454379
https://pubmed.ncbi.nlm.nih.gov/23454379
Autor:
Karin Hagen, Ola Weiland, Loa Davidsdottir, Antti Oksanen, Markus Birk, Nogol Rahbin, Tony Carlsson, Eliya Syed, Soo Aleman, Rolf Hultcrantz
Publikováno v:
Scandinavian journal of gastroenterology. 43(11)
Pegylated interferon (peg-IFN) and ribavirin (RBV) treatment is less effective in patients with hepatitis C virus (HCV) and liver cirrhosis than in non-cirrhotic patients. Many patients with advanced liver disease have been excluded from the pivotal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7156a3df997c832b1aabf563b14c59d5
https://pubmed.ncbi.nlm.nih.gov/18615358
https://pubmed.ncbi.nlm.nih.gov/18615358